首頁 > 市場調查報告書 > 製藥

OTC 非處方藥

市場調查報告書

商品編碼

1785397

消費者保健市場－全球產業規模、佔有率、趨勢、機會和預測（按產品、配銷通路、地區和競爭細分，2020-2030 年）

Consumer Healthcare Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Distribution Channel, By Region and Competition, 2020-2030F

出版日期: 2025年08月06日 | 出版商:

TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

到 2024 年，全球消費者保健市場規模將達到 4,056.4 億美元，預計在預測期內將實現令人印象深刻的成長，到 2030 年的複合年成長率將達到 8.14%。消費者保健市場涵蓋與健康、口腔健康、營養和皮膚健康相關的各種產品。這些產品主要包括非處方藥 (OTC)，消費者無需醫療保健專業人員的處方即可直接購買。推動消費者保健市場成長的因素有很多。首先，人們對以病人為中心的治療的需求日益成長，個人對自身健康和福祉的掌控力也越來越強。其次，醫療基礎設施的改善使更多人更容易獲得消費者保健產品。

市場概覽
預測期	2026-2030
2024年市場規模	4056.4億美元
2030年市場規模	6435.7億美元
2025-2030 年複合年成長率	8.14%
成長最快的領域	膳食補充劑
最大的市場	北美洲

消費者保健市場的主要驅動力之一是自我藥療的興起。隨著醫療成本的成長，人們開始將非處方藥（OTC）產品視為比處方藥更具成本效益的替代品。老年人口的成長（老年人更容易感染疾病）也推動了消費者保健產品的需求。心理健康狀況的惡化是推動市場成長的另一個因素，因為越來越多的人正在尋求非處方藥（OTC）來改善心理健康。健康和預防醫學的獲批，加上可支配收入的增加，進一步推動了消費者保健市場的成長。

老年人口的成長預計將對消費保健市場的擴張起到重要作用。根據世界衛生組織 (WHO) 的數據，到 2050 年，全球 60 歲及以上人口將達到 21 億。這些老年人口更容易患上與年齡相關的疾病，例如消化系統疾病和肌肉疼痛，這反過來又推動了對非處方藥和膳食補充劑的需求。

關鍵市場促進因素

健康意識的提高

主要市場挑戰

監理合規性激增

主要市場趨勢

天然和草本產品需求不斷成長

Global Consumer Healthcare Market was reached reach USD 405.64 billion by 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.14% through 2030. The consumer healthcare market encompasses a wide range of products related to wellness, oral health, nutrition, and skin health. These products primarily consist of over the counter (OTC) drugs that can be purchased directly by consumers without a prescription from a healthcare professional. There are several factors driving the growth of the consumer healthcare market. There is an increasing demand for patient-centric treatments, where individuals are taking more control of their own health and well-being. The improvements in healthcare infrastructure have made consumer healthcare products more accessible to a larger population.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 405.64 Billion
Market Size 2030	USD 643.57 Billion
CAGR 2025-2030	8.14%
Fastest Growing Segment	Dietary Supplements
Largest Market	North America

One of the key drivers of the consumer healthcare market is the rising trend of self-medication. With the growth in healthcare costs, people are turning to OTC products as a more cost-effective alternative to prescription medications. The increase in the geriatric population, who are more prone to contracting diseases, has also contributed to the demand for consumer healthcare products. Mental health deterioration is another factor driving the market, as more people are seeking OTC solutions for their mental well-being. The approval of wellness and preventive medicine, coupled with the rise in disposable income, has further boosted the growth of the consumer healthcare market.

The growth in the geriatric population is expected to play a significant role in the expansion of the consumer healthcare market. According to the World Health Organization (WHO), by 2050, the global population of individuals aged 60 years and older will reach 2.1 billion. This aging population is more susceptible to age-related diseases, such as digestive disorders and muscle pain, which in turn drives the demand for OTC pharmaceuticals and dietary supplements.

Key Market Drivers

Rise in Health Awareness

Health awareness plays a crucial and ever-evolving role in shaping the dynamic consumer healthcare market. In this age of technological advancements, individuals now have unprecedented access to a vast array of health-related information. From understanding the intricacies of disease symptoms to delving into comprehensive research on preventive measures and treatment options, the digital world has truly revolutionized the way we acquire knowledge about our well-being. For instance, in August 2024, Pfizer and Eli Lilly announced plans to sell their medications directly to consumers, bypassing traditional pharmacy channels. This strategic shift aims to improve access, reduce costs, and streamline the purchasing process for patients. By embracing a direct-to-consumer model, both companies seek to strengthen customer engagement, enhance brand loyalty, and respond to growing demand for more convenient and affordable healthcare solutions.

This newfound accessibility to health information has given rise to a generation of more informed consumers who are increasingly proactive when it comes to their own health. Gone are the days when individuals solely focused on treating illnesses; now, consumers are taking charge of their well-being by adopting preventive healthcare measures. This transformative trend is clearly evident in the growing demand for vitamins and dietary supplements, fitness equipment, and routine health check-ups.

Digital platforms have emerged as powerful catalysts in promoting health awareness on a global scale. From ubiquitous social media platforms to innovative health apps and informative online platforms, individuals now have an abundance of resources to aid them in their journey towards better health and wellness. These digital avenues empower individuals to make informed decisions and take responsibility for their own well-being. These platforms have created unprecedented opportunities for companies to connect with consumers, offering a diverse range of health products and driving the growth of the consumer healthcare market.

Another notable shift in consumer behavior is the growing preference for self-medication, which has led to a significant rise in the sales of over-the-counter (OTC) products. Consumers are increasingly seeking out dietary supplements to enhance their immune systems and maintain a balanced and healthy lifestyle.

As the world continues to evolve, health awareness will remain a pivotal force shaping the consumer healthcare market. With technology as an enabler, the possibilities for further advancement and innovation in promoting health and wellness are limitless.

Key Market Challenges

Surge in Regulatory Compliance

Regulatory compliance is a critical aspect of business operations, particularly in the consumer healthcare market. It encompasses the meticulous process of ensuring adherence to laws, regulations, guidelines, and specifications that govern various business processes. By complying with these regulations, organizations can guarantee the safety, efficacy, and quality of healthcare products and services.

However, the surge in regulatory compliance poses significant challenges for businesses operating in the consumer healthcare market. With strict regulations enforced by authorities such as the Food and Drug Administration (FDA) in the U.S. and the European Medicines Agency (EMA) in Europe, companies must navigate a complex landscape of evolving requirements. Staying up-to-date and ensuring compliance can be a daunting task, as failure to do so can result in hefty fines, legal consequences, damage to brand reputation, and loss of consumer trust.

Adding to the complexity is the global nature of the consumer healthcare market, where companies must adhere to diverse regulatory standards across different countries and regions. This diversity further amplifies the challenges faced by businesses, requiring them to allocate significant resources to navigate and comply with a multitude of regulations.

The surge in regulatory compliance has a profound impact on the consumer healthcare market. It drives up the cost of product development and extends the time-to-market, ultimately reducing overall profitability. The fear of non-compliance can hinder innovation, as companies may become risk-averse to avoid potential regulatory pitfalls.

Key Market Trends

Growing Demand of Natural and Herbal Products

Natural and herbal products have been utilized for centuries in traditional medicine systems across diverse cultures, owing to their perceived therapeutic properties. In recent years, these products have experienced a surge in popularity, making their way into mainstream consumer healthcare. This shift can be attributed to a growing awareness of their potential health benefits and an increasing preference for natural alternatives over synthetic counterparts.

Consumers are now actively seeking out natural and herbal alternatives for a wide range of health issues. From common ailments like colds and flu to chronic conditions such as heart disease and diabetes, individuals are exploring the potential benefits of these products. This trend expands beyond medications alone and encompasses natural supplements, skincare products, and even food and beverages with health-boosting properties.

Several factors contribute to the escalating demand for natural and herbal products in the consumer healthcare market. Firstly, a mounting body of scientific research supports the efficacy of specific natural and herbal remedies, validating their usage and instilling confidence in consumers. Secondly, individuals are becoming increasingly health-conscious and proactive in their pursuit of well-being. They are now more aware of the potential side effects associated with synthetic drugs and are actively seeking safer and more natural alternatives.

The advent of digital platforms has significantly facilitated consumer access to information about natural and herbal products. Through online channels, individuals can easily gather knowledge about these products and make informed purchase decisions. This accessibility has further fueled the growth of the natural and herbal product market.

This prevailing trend has not only spurred innovation in the market but has also prompted companies to invest in research and development to create novel natural and herbal products. The growing demand has attracted new players to enter the market, intensifying competition and driving further advancements.

Key Market Players

Johnson & Johnson (Kenvue Inc.)
Haleon Plc
Bayer AG
Procter & Gamble Company
Sanofi SA
BASF SE
Teva Pharmaceutical Industries
Abbott Laboratories
STADA Arzneimittel AG
Amway Corporation

Report Scope:

In this report, the Global Consumer Healthcare Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Consumer Healthcare Market, By Product:

OTC Pharmaceuticals
Dietary Supplements
Others

Consumer Healthcare Market, By Distribution Channel:

Retail
Online
Hospitals

Consumer Healthcare Market, By Region:

North America
Europe
Asia Pacific
South America
Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Consumer Healthcare Market.

Available Customizations:

Global Consumer Healthcare Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Applications
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Impact of COVID-19 on Global Consumer Healthcare Market

5. Voice of Customers

5.1. Factors Affecting Purchase Decision
5.2. Brand Awareness
5.3. Sources of Information
5.4. Product Preferences
5.5. Trends and Innovation

6. Global Consumer Healthcare Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Product (OTC Pharmaceuticals, Dietary Supplements, Others)
- 6.2.2. By Distribution Channel (Retail, Online, Hospitals)
- 6.2.3. By Region
6.3. By Company (2024)
6.4. Market Map (By Product, By Distribution Channel, By Region)

7. Asia Pacific Consumer Healthcare Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By Distribution Channel
- 7.2.3. By Country
7.3. Asia Pacific: Country Analysis
- 7.3.1. China Consumer Healthcare Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Product
    - 7.3.1.2.2. By Distribution Channel
- 7.3.2. India Consumer Healthcare Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Product
    - 7.3.2.2.2. By Distribution Channel
- 7.3.3. Australia Consumer Healthcare Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Product
    - 7.3.3.2.2. By Distribution Channel
- 7.3.4. Japan Consumer Healthcare Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Product
    - 7.3.4.2.2. By Distribution Channel
- 7.3.5. South Korea Consumer Healthcare Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Product
    - 7.3.5.2.2. By Distribution Channel

8. Europe Consumer Healthcare Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By Distribution Channel
- 8.2.3. By Country
8.3. Europe: Country Analysis
- 8.3.1. France Consumer Healthcare Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Product
    - 8.3.1.2.2. By Distribution Channel
- 8.3.2. Germany Consumer Healthcare Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Product
    - 8.3.2.2.2. By Distribution Channel
- 8.3.3. Spain Consumer Healthcare Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Product
    - 8.3.3.2.2. By Distribution Channel
- 8.3.4. Italy Consumer Healthcare Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Product
    - 8.3.4.2.2. By Distribution Channel
- 8.3.5. United Kingdom Consumer Healthcare Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Product
    - 8.3.5.2.2. By Distribution Channel

9. North America Consumer Healthcare Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Distribution Channel
- 9.2.3. By Country
9.3. North America: Country Analysis
- 9.3.1. United States Consumer Healthcare Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Product
    - 9.3.1.2.2. By Distribution Channel
- 9.3.2. Mexico Consumer Healthcare Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Product
    - 9.3.2.2.2. By Distribution Channel
- 9.3.3. Canada Consumer Healthcare Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Product
    - 9.3.3.2.2. By Distribution Channel

10. South America Consumer Healthcare Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Product
- 10.2.2. By Distribution Channel
- 10.2.3. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Consumer Healthcare Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Product
    - 10.3.1.2.2. By Distribution Channel
- 10.3.2. Argentina Consumer Healthcare Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Product
    - 10.3.2.2.2. By Distribution Channel
- 10.3.3. Colombia Consumer Healthcare Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Product
    - 10.3.3.2.2. By Distribution Channel

11. Middle East and Africa Consumer Healthcare Market Outlook

11.1. Market Size & Forecast
- 11.1.1. By Value
11.2. Market Share & Forecast
- 11.2.1. By Product
- 11.2.2. By Distribution Channel
- 11.2.3. By Country
11.3. MEA: Country Analysis
- 11.3.1. South Africa Consumer Healthcare Market Outlook
  - 11.3.1.1. Market Size & Forecast
    - 11.3.1.1.1. By Value
  - 11.3.1.2. Market Share & Forecast
    - 11.3.1.2.1. By Product
    - 11.3.1.2.2. By Distribution Channel
- 11.3.2. Saudi Arabia Consumer Healthcare Market Outlook
  - 11.3.2.1. Market Size & Forecast
    - 11.3.2.1.1. By Value
  - 11.3.2.2. Market Share & Forecast
    - 11.3.2.2.1. By Product
    - 11.3.2.2.2. By Distribution Channel
- 11.3.3. UAE Consumer Healthcare Market Outlook
  - 11.3.3.1. Market Size & Forecast
    - 11.3.3.1.1. By Value
  - 11.3.3.2. Market Share & Forecast
    - 11.3.3.2.1. By Product
    - 11.3.3.2.2. By Distribution Channel

12. Market Dynamics

12.1. Drivers
12.2. Challenges

13. Market Trends & Developments

13.1. Recent Developments
13.2. Product Launches
13.3. Mergers & Acquisitions

14. Global Consumer Healthcare Market: SWOT Analysis

15. Porter's Five Forces Analysis

15.1. Competition in the Industry
15.2. Potential of New Entrants
15.3. Power of Suppliers
15.4. Power of Customers
15.5. Threat of Substitute Product

16. Competitive Landscape

16.1. Johnson & Johnson (Kenvue Inc.)
- 16.1.1. Business Overview
- 16.1.2. Company Snapshot
- 16.1.3. Products & Services
- 16.1.4. Financials (As Reported)
- 16.1.5. Recent Developments
16.2. Haleon Plc
16.3. Bayer AG
16.4. Procter & Gamble Company
16.5. Sanofi SA
16.6. BASF SE
16.7. Teva Pharmaceutical Industries
16.8. Abbott Laboratories
16.9. STADA Arzneimittel AG
16.10. Amway Corporation